Drug recall
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA…
FDA recall event 99492 · Class II · Aurobindo Pharma USA Inc
Key facts
| Event ID | 99492 |
|---|---|
| Recall numbers | D-0733-2026 |
| Recalling firm | Aurobindo Pharma USA Inc |
| Product type | Drugs |
| Products | Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | shortfill; reports of empty capsules. |
| Initiation date | Jul 23, 2026 |
| Report date | Aug 12, 2026 |
| City | East Windsor |
| State | NJ |
| Country | United States |
| FEI number | 3008460374 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: